Equities

Sotera Health Co

SHC:NSQ

Sotera Health Co

Actions
Health CareMedical Equipment and Services
  • Price (USD)11.18
  • Today's Change0.09 / 0.81%
  • Shares traded1.96m
  • 1 Year change-20.65%
  • Beta2.0695
Data delayed at least 15 minutes, as of May 31 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sotera Health Company is a global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. The Company’s segments include Sterigenics, Nordion, and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. The Nordion business is a provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and materials industries and for the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. The Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.

  • Revenue in USD (TTM)1.08bn
  • Net income in USD54.57m
  • Incorporated2015
  • Employees3.00k
  • Location
    Sotera Health Co9100 South Hills BlvdSuite 300, Suite 300BROADVIEW HEIGHTS 44147United StatesUSA
  • Phone+1 (440) 262-1410
  • Fax+1 (302) 636-5454
  • Websitehttps://soterahealth.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CarGurus Inc898.08m36.27m2.52bn1.34k75.534.4849.022.810.32060.32068.015.410.9343223.5116.76668,708.103.289.893.8212.5074.7664.963.517.102.78--0.000.00-44.7615.02-83.95-13.7540.68--
Ziff Davis Inc1.37bn59.76m2.66bn4.20k44.541.409.121.941.291.2929.6841.230.3781--3.78326,516.901.673.261.973.9485.5285.164.428.94--5.500.3457.61-1.942.47-36.58-20.0213.77--
ICF International Inc1.97bn93.53m2.67bn9.00k28.972.9217.531.354.934.93104.0048.850.9654--4.69219,376.904.573.975.595.0936.0335.954.744.13--4.000.348715.4210.307.9728.596.110.47680.00
Frontdoor Inc1.79bn183.00m2.75bn1.72k15.6017.0912.451.542.272.2722.312.071.58--358.201,043,706.0016.2710.8524.3715.8350.7547.8610.338.08--12.260.78460.007.107.19140.856.473.46--
Global Business Travel Group Inc2.32bn-80.00m2.87bn19.00k--2.4542.821.24-0.3694-0.36946.622.480.5966--2.67122,210.50-3.29---5.42--58.57---5.51----0.71430.5373--23.72---152.00------
Goodrx Holdings Inc764.16m-6.59m2.95bn694.00--4.6828.933.86-0.018-0.0181.891.680.4986--5.851,101,094.00-0.4298-4.89-0.4574-5.1791.8093.05-0.862-9.20--0.83770.5088---2.1224.6372.99--74.38--
UniFirst Corp2.33bn114.69m2.96bn16.00k25.951.4511.941.276.116.11124.31109.740.91939.948.21145,799.604.525.985.016.6434.1035.574.926.962.69--0.0013.1511.615.650.2611-6.338.8140.46
ABM Industries Inc8.17bn257.50m2.99bn123.00k12.071.647.980.3663.923.92124.6628.801.66--5.6266,460.985.223.506.934.7412.9714.163.152.13--5.160.421634.993.714.689.0728.805.014.23
Sotera Health Co1.08bn54.57m3.16bn3.00k58.067.3713.802.940.19260.19263.811.520.33279.878.36358,958.001.69-0.8681.92-0.966455.0554.405.09-2.682.862.350.8439--4.547.06121.87--24.24--
Instructure Holdings Inc556.82m-43.35m3.23bn1.50k--2.5328.835.80-0.2994-0.29943.858.760.2293--9.62372,207.20-1.78---2.01--65.9361.62-7.78-22.22--0.58360.4733--11.5820.400.4789---11.81--
Korn Ferry2.83bn148.43m3.44bn10.70k22.832.0314.891.212.892.8955.1432.550.814--4.65264,906.604.456.005.908.0487.8793.495.477.73----0.188615.288.349.50-35.777.1810.888.45
ManpowerGroup Inc18.57bn50.70m3.56bn27.90k76.561.6525.440.19170.97460.9746373.9345.312.14--4.02665,430.100.58352.891.236.1317.5516.820.27311.36--3.810.310450.90-4.60-2.97-76.24-30.653.867.80
Insperity Inc6.52bn155.79m3.57bn4.40k23.1624.8917.920.54724.094.09170.793.813.13--9.791,481,413.007.489.0721.3824.9116.1016.952.392.94----0.72554.579.2111.12-4.445.122.5822.76
Data as of May 31 2024. Currency figures normalised to Sotera Health Co's reporting currency: US Dollar USD

Institutional shareholders

24.94%Per cent of shares held by top holders
HolderShares% Held
Janus Henderson Investors US LLCas of 31 Mar 202414.64m5.18%
The Vanguard Group, Inc.as of 31 Mar 202411.98m4.24%
BlackRock Fund Advisorsas of 31 Mar 202410.18m3.60%
Sachem Head Capital Management LPas of 31 Mar 20247.91m2.80%
T. Rowe Price Investment Management, Inc.as of 31 Mar 20245.04m1.78%
MIG Capital LLCas of 31 Mar 20245.04m1.78%
ArrowMark Colorado Holdings LLCas of 31 Mar 20244.74m1.67%
Sessa Capital IM LPas of 31 Mar 20244.00m1.41%
Maverick Capital Ltd.as of 31 Mar 20243.57m1.26%
SSgA Funds Management, Inc.as of 31 Mar 20243.46m1.22%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.